Patients younger than 50 diagnosed with non-small cell lung cancer have a higher likelihood of having a targetable genomic alteration for which therapies exist, says a study of more than 2,000 patients (Sacher AG, et al. JAMA Oncol. Published online ahead of print Dec. 17, 2015. doi:10.1001/jamaoncol.2015.4482). Geoffrey R. Oxnard, MD, of the Dana-Farber Cancer […]
